Invention Grant
- Patent Title: Substituted 4-azaindoles and their use as GluN2B receptor modulators
-
Application No.: US15205632Application Date: 2016-07-08
-
Publication No.: US09963447B2Publication Date: 2018-05-08
- Inventor: Christa C. Chrovian , Michael A. Letavic , Jason C. Rech , Akinola Soyode-Johnson , Jessica L. Wall
- Applicant: JANSSEN PHARMACEUTICA NV
- Applicant Address: BE
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
Substituted 4-azaindoles as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.
Public/Granted literature
- US20170008890A1 SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Public/Granted day:2017-01-12
Information query
